Clinical Trial Update: Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety and immunogenicity results from Phase 1/Phase 2 testing of an investigational influenza and COVID-19 combination vacci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Drugs mentioned

• Influenza and COVID-19 Combination Vaccine

Snippet

Sponsor: Novavax | Conditions: SARS-CoV Infection, Covid19 | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-10